CARSTEN BOESS

Insider Reports History

Location
Hamilton, Bermuda
Signature
/s/ Adam Grajewski, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CARSTEN BOESS:

Company Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Director Common Stock 30,000 $73,518 $2.45 18 Jun 2025 Direct
Avidity Biosciences, Inc. Director Common Stock 0 $0 $72.51 27 Feb 2026 Direct
Atrium Therapeutics, Inc. Director Stock Option (Right to Buy) 20,000 27 Feb 2026 Direct
Atrium Therapeutics, Inc. Director Common Stock 11,005 26 Feb 2026 Direct
Avidity Biosciences, Inc. Director Stock Option (Right to Buy) 0 27 Feb 2026 Direct

Insider Reports Filed by CARSTEN BOESS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000119312526085921-boess-carsten-2026-02-27 Atrium Therapeutics, Inc. 27 Feb 2026 1 $0 4 Director 02 Mar 2026, 18:00
RNA Avidity Biosciences, Inc. 27 Feb 2026 7 $0 4 Director 27 Feb 2026, 14:50
/report/000119312526077764-boess-carsten-2026-02-26 Atrium Therapeutics, Inc. 26 Feb 2026 0 $0 3 Director 26 Feb 2026, 18:16
RCKT ROCKET PHARMACEUTICALS, INC. 18 Jun 2025 1 $0 4 Director 18 Jul 2025, 16:05
RNA Avidity Biosciences, Inc. 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 18:40
RCKT ROCKET PHARMACEUTICALS, INC. 13 Jun 2024 1 $0 4 Director 20 Jun 2024, 16:10
RNA Avidity Biosciences, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 19:01
RCKT ROCKET PHARMACEUTICALS, INC. 22 Jun 2023 1 $0 4 Director 26 Jun 2023, 19:47
RNA Avidity Biosciences, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 16:01
RNA Avidity Biosciences, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 20:44
RCKT ROCKET PHARMACEUTICALS, INC. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 21:07
RNA Avidity Biosciences, Inc. 16 Jun 2021 1 $0 4 Director 16 Jun 2021, 19:59
RCKT ROCKET PHARMACEUTICALS, INC. 14 Jun 2021 1 $0 4 Director 16 Jun 2021, 20:07